Rainbow Child.

Has Rainbow Child. declared dividend?

Rainbow Childrens Medicare Ltd has declared a 30% dividend, amounting to 3 per share, with an ex-date of June 27, 2025. The dividend yield is 0.21%, and total returns have varied across periods, showing significant growth over the long term despite short-term declines.

Rainbow Childrens Medicare Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 27 Jun 25<BR><BR>Dividend Yield: 0.21%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -14.08%, the dividend return was 0.18%, resulting in a total return of -13.9%.<BR><BR>Over the past year, the price return was 8.36%, the dividend return was 0.46%, leading to a total return of 8.82%.<BR><BR>In the 2-year period, the price return was 52.26%, the dividend return was 0.94%, culminating in a total return of 53.2%.<BR><BR>For the 3-year period, the price return was 196.48%, the dividend return was 2.53%, resulting in a total return of 199.01%.<BR><BR>In the 4-year period, there was no price return, no dividend return, and a total return of 0.0%.<BR><BR>Similarly, in the 5-year period, there was no price return, no dividend return, and a total return of 0.0%.<BR><BR>Overall, Rainbow Childrens Medicare Ltd has declared a dividend and has shown varying total returns across different periods, with significant growth in the longer terms despite some negative performance in the short term. The dividend yield indicates a modest return relative to the share price.

Is Rainbow Child. overvalued or undervalued?

As of June 12, 2023, Rainbow Child is considered very expensive and overvalued with a PE ratio of 58.94, a Price to Book Value of 9.77, and an EV to EBITDA ratio of 29.64, despite a strong three-year stock performance of 199.47%.

As of 12 June 2023, the valuation grade for Rainbow Child. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued, with a PE ratio of 58.94, a Price to Book Value of 9.77, and an EV to EBITDA ratio of 29.64. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Rainbow Child. has a higher PE ratio than Max Healthcare Institute Ltd. at 100.29 and Apollo Hospitals Enterprise Ltd. at 69.03, both of which are also categorized as very expensive. The PEG ratio of 4.86 further underscores the overvaluation, especially when compared to peers like Narayana Hrudayalaya Ltd. with a PEG of 37.59. Despite a strong stock performance over the past three years, with a return of 199.47%, the current valuation metrics indicate that Rainbow Child. is not justified at its current price of 1408.40.

Who are the peers of the Rainbow Child.?

Peers of Rainbow Child include Fortis Health, Narayana Hrudaya, Global Health, Aster DM Health, Krishna Institute, Dr. Agarwal's Health, Jupiter Life Line, Health.Global, and Kovai Medical. Rainbow Child has good management risk and a 1-year return of 29.99%, lower than Fortis Health's 62.86%.

Peers: The peers of Rainbow Child are Fortis Health., Narayana Hrudaya, Global Health, Aster DM Health., Krishna Institu., Dr Agarwal's Hea, Jupiter Life Lin, Health.Global, and Kovai Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Narayana Hrudaya, Global Health, Dr Agarwal's Hea, Jupiter Life Lin, and Kovai Medical, while Average management risk is found at Fortis Health. Good management risk is noted for Rainbow Child and Health.Global. In terms of growth, Good growth is seen at Narayana Hrudaya, Dr Agarwal's Hea, and Health.Global, while Below Average growth is present at Aster DM Health., Rainbow Child, Krishna Institu., and Kovai Medical. For capital structure, Excellent capital structure is noted at Global Health and Krishna Institu., while Good capital structure is observed at Fortis Health, Rainbow Child, Dr Agarwal's Hea, and Kovai Medical, with Below Average capital structure at Aster DM Health. and Health.Global.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Fortis Health. at 62.86%, while the lowest is Dr Agarwal's Hea with N/A, and Rainbow Child's 1-year return of 29.99% is lower than Fortis Health's. Additionally, Jupiter Life Lin has a negative six-month return of -3.18%.

Who are in the management team of Rainbow Child.?

As of March 2023, the management team of Rainbow Child includes Ramesh Kancharla (Chairman & Managing Director), Dinesh Kumar Chirla (Whole-time Director), and five Independent Directors: Aluri Rao Srinivasa, Anil Dhawan, Sundari Raviprasad Pisupati, Santanu Mukherjee, and Ashish Kapil (Company Secretary & Compliance Officer). They oversee the company's operations and strategic direction.

As of March 2023, the management team of Rainbow Child includes the following individuals:<BR><BR>1. Ramesh Kancharla - Chairman & Managing Director<BR>2. Dinesh Kumar Chirla - Whole-time Director<BR>3. Aluri Rao Srinivasa - Independent Director<BR>4. Anil Dhawan - Independent Director<BR>5. Sundari Raviprasad Pisupati - Independent Director<BR>6. Santanu Mukherjee - Independent Director<BR>7. Ashish Kapil - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

What does Rainbow Child. do?

Rainbow Childrens Medicare Ltd is a mid-cap company in the hospital industry, reporting net sales of 3,701 Cr and a net profit of 563 Cr for the quarter ending March 2025. It has a market cap of INR 15,613 Cr, a P/E ratio of 64.00, and a dividend yield of 0.40%.

Overview:<BR>Rainbow Childrens Medicare Ltd operates in the hospital industry and is categorized as a mid-cap company.<BR><BR>History:<BR>The company was originally incorporated as Rainbow Children's Medicare Private Limited in 1998 and later converted to a public limited company, changing its name to Rainbow Children's Medicare Limited on November 20, 2021. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 3,701 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 563 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 15,613 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 64.00<BR>- Industry P/E: 59<BR>- Dividend Yield: 0.40%<BR>- Debt Equity: 0.12<BR>- Return on Equity: 16.58%<BR>- Price to Book: 10.50<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the top shareholders of the Rainbow Child.?

The top shareholders of Rainbow Child include Ramesh Kancharla with 31.04%, 23 mutual funds holding 11.47%, and 188 foreign institutional investors with 23.69%. The highest public shareholder is the DSP Aggressive Hybrid Fund at 4.27%, while individual investors own 10.34% of the shares.

The top shareholders of Rainbow Child include the promoters, with Ramesh Kancharla holding the highest individual stake at 31.04%. Additionally, the company has significant institutional investment, with 23 mutual funds collectively holding 11.47% and 188 foreign institutional investors (FIIs) holding 23.69%. The highest public shareholder is the DSP Aggressive Hybrid Fund, which holds 4.27%. Individual investors also have a notable presence, owning 10.34% of the shares.

How big is Rainbow Child.?

As of 24th July, Rainbow Childrens Medicare Ltd has a market capitalization of 15,730.00 Cr, with recent net sales of 1,515.87 Cr and a net profit of 243.43 Cr. Shareholder's funds are 1,468.19 Cr and total assets are 2,347.40 Cr as of March 2025.

As of 24th July, Rainbow Childrens Medicare Ltd has a market capitalization of 15,730.00 Cr and is classified as a Mid Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 1,515.87 Cr and a Net Profit of 243.43 Cr.<BR><BR>For the latest annual period ending March 2025, the Shareholder's Funds amounted to 1,468.19 Cr, while the Total Assets were reported at 2,347.40 Cr.

How has been the historical performance of Rainbow Child.?

Rainbow Child has shown consistent growth over the past six years, with net sales increasing from 650.05 Cr in Mar'21 to 1,515.87 Cr in Mar'25, and profit after tax rising from 39.57 Cr to 244.23 Cr. The company has eliminated long-term debt and improved cash flow, indicating strong financial health.

Answer:<BR>The historical performance of Rainbow Child shows a consistent growth trend across various financial metrics over the past six years.<BR><BR>Breakdown:<BR>Rainbow Child's net sales have increased significantly from 650.05 Cr in Mar'21 to 1,515.87 Cr in Mar'25, reflecting a strong upward trajectory. Total operating income followed a similar trend, rising from 719.39 Cr in Mar'20 to 1,515.87 Cr in Mar'25. The company's operating profit (PBDIT) also saw substantial growth, climbing from 173.10 Cr in Mar'21 to 540.90 Cr in Mar'25, although the operating profit margin slightly decreased from 33.07% in Mar'24 to 32.32% in Mar'25. Profit before tax rose from 55.70 Cr in Mar'21 to 330.00 Cr in Mar'25, while profit after tax increased from 39.57 Cr in Mar'21 to 244.23 Cr in Mar'25, showcasing improved profitability. The total assets of the company grew from 1,018.89 Cr in Mar'20 to 2,347.40 Cr in Mar'25, indicating a solid expansion in the asset base. Furthermore, the company has eliminated long-term borrowings, achieving a total debt of 0.00 Cr in Mar'25, which reflects a strong financial position. Cash flow from operating activities has also improved, rising from 142.00 Cr in Mar'21 to 395.00 Cr in Mar'25, contributing to a net cash inflow of 10.00 Cr in Mar'25. Overall, Rainbow Child has demonstrated robust growth and financial health over the years.

Is Rainbow Child. technically bullish or bearish?

As of December 1, 2025, the technical trend is mildly bearish, influenced by bearish indicators from the weekly MACD and moving averages, despite some bullish momentum in the weekly RSI and mixed monthly signals.

As of 1 December 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD and Bollinger Bands indicating bearish conditions, while the daily moving averages also reflect a bearish outlook. The weekly RSI shows bullish momentum, but the overall monthly indicators remain mixed, with the KST showing bullish on a monthly basis. Dow Theory suggests a mildly bullish stance on the weekly timeframe, but with no clear trend on the monthly. The stock's recent performance against the Sensex has been negative across multiple time frames, further supporting the bearish sentiment.

When is the next results date for Rainbow Childrens Medicare Ltd?

The next results date for Rainbow Childrens Medicare Ltd is January 28, 2026.

The next results date for Rainbow Childrens Medicare Ltd is scheduled for January 28, 2026.

Are Rainbow Childrens Medicare Ltd latest results good or bad?

Rainbow Childrens Medicare Ltd's latest results show mixed performance, with a year-on-year profit growth of 5.59% but a quarter-on-quarter net profit decline of 3.61% and compressed operating margins, indicating operational challenges and raising concerns about sustainability. Overall, the results are more concerning than encouraging.

The latest results for Rainbow Childrens Medicare Ltd indicate a mixed performance, leaning towards the negative side. While the company achieved a year-on-year profit growth of 5.59%, it faced significant challenges in the most recent quarter. The net profit declined by 3.61% quarter-on-quarter to ₹72.53 crores, and revenue growth was minimal at just 0.15% sequentially. <BR><BR>Moreover, the operating margin has also compressed, falling to 33.0%, which is a decline from the previous quarter. This margin pressure, combined with the tepid revenue growth, raises concerns about the sustainability of the company's expansion in a competitive healthcare landscape. <BR><BR>Overall, while there are some positive year-on-year metrics, the sequential declines in both net profit and operating margin suggest that the company is grappling with operational challenges, making the latest results more concerning than encouraging.

Should I buy, sell or hold Rainbow Childrens Medicare Ltd?

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 17-Mar, Rainbow Childrens Medicare Ltd's stock price is rising to 1,128.25 after a trend reversal, but it has a negative long-term outlook with a year-to-date decline of 14.51% and decreasing investor participation. Despite high management efficiency and institutional backing, concerns about growth persist as the stock has underperformed the market.

As of 17-Mar, Rainbow Childrens Medicare Ltd's stock price is rising, currently at 1,128.25, reflecting a change of 16.4 (1.48%) upward. This increase comes after a trend reversal, as the stock has gained after three consecutive days of decline. Additionally, it has outperformed its sector by 0.93% today. <BR><BR>Despite this positive movement, the stock has shown a negative performance over the longer term, with a year-to-date decline of 14.51% and a one-year drop of 9.62%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Furthermore, there has been a significant decrease in investor participation, with delivery volume falling by 32% against the 5-day average.<BR><BR>On the positive side, the company demonstrates high management efficiency with a return on capital employed (ROCE) of 19.68% and a low debt-to-EBITDA ratio of 0.84 times, indicating a strong ability to service debt. Additionally, high institutional holdings at 38.72% suggest that knowledgeable investors are backing the company.<BR><BR>However, concerns about long-term growth persist, as net sales and operating profit have only grown at annual rates of 14.91% and 15.53%, respectively, over the past five years. The stock has underperformed the market significantly, generating negative returns while the broader market has seen positive growth.<BR><BR>In summary, while the stock is currently rising due to a short-term trend reversal and sector outperformance, its long-term outlook remains challenged by poor growth metrics and recent declines in investor participation.

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 18-Mar, the stock price of Rainbow Childrens Medicare Ltd is at 1,118.70, reflecting a decline of 0.82%. The stock has underperformed significantly over various periods, with decreased investor interest and poor long-term growth metrics contributing to its bearish trend.

As of 18-Mar, the stock price of Rainbow Childrens Medicare Ltd is falling, currently at 1,118.70, reflecting a decrease of 9.2 points or 0.82%. This decline is part of a broader trend, as the stock has underperformed significantly over various time periods, including a 7.01% drop over the past week and a 15.23% decline year-to-date. <BR><BR>The stock's performance today has also been disappointing, underperforming its sector by 2.12%. Additionally, it is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. <BR><BR>Investor participation has decreased, with delivery volume falling by 45.73% compared to the 5-day average, suggesting a lack of interest from investors. Although the company has strong management efficiency and a low debt-to-EBITDA ratio, these positive factors are overshadowed by poor long-term growth metrics, such as a net sales growth rate of only 14.91% over the past five years and a low debtors turnover ratio. <BR><BR>Furthermore, the stock has underperformed the market significantly over the last year, generating negative returns of -13.97% while the broader market has seen positive returns. This combination of declining performance metrics, reduced investor interest, and underwhelming growth prospects contributes to the stock's falling price.

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 19-Mar, the stock price of Rainbow Childrens Medicare Ltd is currently at 1,100.00, reflecting a decline of 2.1% and part of a broader downward trend. The stock has underperformed over the past year with a return of -14.65%, while the healthcare sector also faces challenges, contributing to its bearish momentum.

As of 19-Mar, the stock price of Rainbow Childrens Medicare Ltd is falling, currently at 1,100.00, which reflects a decrease of 23.55 or 2.1%. This decline is part of a broader trend, as the stock has been losing value for the last two days, resulting in a total drop of 2.47% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish momentum.<BR><BR>In the context of market performance, the stock has underperformed significantly over the past year, generating a return of -14.65%, while the broader market (BSE500) has seen a positive return of 1.22%. The company's net sales growth has been modest at an annual rate of 14.91% over the last five years, and despite a low Debt to EBITDA ratio of 0.84, which suggests a strong ability to service debt, the overall growth prospects appear limited.<BR><BR>Moreover, the hospital and healthcare services sector has also experienced a decline of 2.8%, contributing to the negative sentiment surrounding the stock. Although there has been a notable increase in investor participation, with delivery volume rising by 234.76% against the 5-day average, this has not translated into a positive price movement. The combination of these factors indicates that the stock is facing downward pressure, leading to its current falling price.

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 20-Mar, the stock price of Rainbow Childrens Medicare Ltd is rising, reflecting a potential trend reversal after previous declines, supported by increased investor participation and strong financial metrics. However, it has underperformed over the past week, month, and year.

As of 20-Mar, the stock price of Rainbow Childrens Medicare Ltd is rising, with a current price of 1,110.30, reflecting an increase of 4.25 (0.38%). This upward movement follows two consecutive days of decline, indicating a potential trend reversal. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 94.22% against the 5-day average, suggesting heightened interest in the stock.<BR><BR>Despite this positive movement today, the stock has experienced a decline over the past week (-2.10%) and month (-7.18%), and it has underperformed the market over the last year with a return of -14.46%. However, the stock's performance today is in line with the sector, and it is trading lower than its moving averages across various time frames, which may indicate a recovery phase.<BR><BR>The company also exhibits strong fundamentals, such as high management efficiency with a return on capital employed (ROCE) of 19.68% and a low debt to EBITDA ratio of 0.84 times, which supports its ability to service debt. Furthermore, high institutional holdings at 38.72% suggest that knowledgeable investors are backing the stock, which could contribute to its price stability and potential rise.<BR><BR>In summary, the current rise in the stock price can be attributed to a combination of a trend reversal after previous declines, increased investor participation, and solid financial metrics, despite the overall underperformance in the longer term.

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 23-Mar, the stock price of Rainbow Childrens Medicare Ltd is currently at 1,103.00, reflecting a bearish trend with significant declines over the past week, month, and year, alongside reduced investor participation and negative sector performance.

As of 23-Mar, the stock price of Rainbow Childrens Medicare Ltd is falling, currently at 1,103.00, which reflects a decrease of 13.95 or 1.25%. This decline is evident from the stock's performance today, where it opened with a loss of 2.78% and reached an intraday low of Rs 1,082.90, marking a drop of 3.05%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>Over the past week, the stock has underperformed the benchmark Sensex, with a decline of 0.80% compared to the Sensex's 3.72% drop. The stock has also shown a significant decline over the past month and year, with losses of 9.33% and 15.29%, respectively. This underperformance is further highlighted by the company's flat results and poor long-term growth, as evidenced by a low annual growth rate in net sales and operating profit over the last five years.<BR><BR>Moreover, there has been a notable decrease in investor participation, with delivery volume falling by 55.78% against the 5-day average, suggesting reduced interest among investors. The overall action in the Hospital & Healthcare Services sector has also been negative, with a decline of 2.37%. These factors combined contribute to the downward pressure on the stock price of Rainbow Childrens Medicare Ltd.

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 24-Mar, Rainbow Childrens Medicare Ltd's stock price is rising to 1,147.25, driven by strong sector performance, increased investor participation, and solid financial metrics. Despite a negative yearly performance, its three-year growth and high management efficiency attract long-term investors.

As of 24-Mar, Rainbow Childrens Medicare Ltd's stock price is rising, currently at 1,147.25, reflecting an increase of 41.1 (3.72%). This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 1.37% today, indicating strong relative performance. Additionally, the stock reached an intraday high of Rs 1154.5, which is a 4.37% increase, showcasing positive momentum.<BR><BR>Investor participation has also increased, with a delivery volume of 1.71 lacs on 23 March, which is up by 52.21% compared to the 5-day average. This rise in trading activity suggests growing interest among investors. Furthermore, the Hospital & Healthcare Services sector, in which the company operates, has gained by 2.35%, contributing to the positive sentiment around the stock.<BR><BR>On a broader scale, despite the stock's negative performance over the past year (-15.46%), it has shown significant growth over the past three years, with a return of +61.52%, which may attract long-term investors. The company also boasts high management efficiency, indicated by a return on capital employed (ROCE) of 19.68%, and a strong ability to service debt, with a low Debt to EBITDA ratio of 0.84 times. High institutional holdings at 38.72% further support the stock's stability, as these investors typically have better resources to analyze the company's fundamentals.<BR><BR>In summary, the combination of strong sector performance, increased investor participation, and solid financial metrics are driving the rise in Rainbow Childrens Medicare Ltd's stock price.

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 25-Mar, the stock price of Rainbow Childrens Medicare Ltd is rising to 1,163.05, reflecting a recent upward trend despite longer-term underperformance and growth concerns. The stock has gained 5.14% over the last two days but has a year-to-date decline of 11.87%.

As of 25-Mar, the stock price of Rainbow Childrens Medicare Ltd is rising, currently at 1,163.05, with a change of 15.8 (1.38%) upward. This increase can be attributed to a few key factors. Firstly, the stock has been gaining for the last two days, showing a cumulative return of 5.14% during this period. Additionally, the stock touched an intraday high of Rs 1181.1, reflecting a 2.95% increase at its peak today.<BR><BR>Despite this recent upward movement, it is important to note that the stock has underperformed its sector by 0.89%. Over the past week, the stock has outperformed the benchmark Sensex, gaining 3.52% while the Sensex declined by 1.87%. However, on a longer-term basis, the stock has faced challenges, with a year-to-date decline of 11.87% and a one-year drop of 13.33%, which is significantly worse than the market's overall performance.<BR><BR>The stock's liquidity remains adequate, with a delivery volume of 64.79k on 24 March, although this represents a significant decrease of 52.66% compared to the five-day average. Furthermore, while the company exhibits high management efficiency with a return on capital employed (ROCE) of 19.68% and a low debt-to-EBITDA ratio of 0.84 times, concerns about its long-term growth persist due to relatively flat net sales and operating profit growth over the past five years.<BR><BR>In summary, while Rainbow Childrens Medicare Ltd is currently experiencing a rise in stock price, this is juxtaposed against a backdrop of longer-term underperformance and concerns regarding growth potential, which may influence investor sentiment moving forward.

Which are the latest news on Rainbow Child.?